chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax;w/in 2-3 hr p/ vax T inc to 102.5;local rxn rt thigh swelling, hot to touch, red, persistent screaming x 2-3 days;PC to MD;apap given;on f/u well baby;
Partial loss of vision in left eye after vaccine; muscle weakness; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient (not pregnant) received the first dose (also reported as second dose, pending clarification) of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number was reported as "ER8730.3ML/M" or "EW0170%ubt2016", pending clarification) via an unspecified route of administration at left arm on 27Mar2021 15:15 (63-year-old at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history included hypertension, arthritis, pneumonia, and allergies to rosemary, day lollies (day lillies). Concomitant medications in two weeks included verapamil HCl, losartan potassium (COZAAR), chlorthalidone, ubidecarenone (COQ10), and vitamin (unspecified). There was no other vaccine in four weeks. The patient experienced partial loss of vision in left eye after vaccine, muscle weakness on 27Mar2021 16:00. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient did not have COVID-19 prior vaccination. Patient was not tested for COVID-19 post vaccination. Therapeutic measures were taken as a result of the event "partial loss of vision in left eye after vaccine" and included "Optomoligist and referral to retina specialist". The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Redness and swelling around site of vaccine, and fever.  Started on the day of vaccination, and ended 3-4 days later.
A cluster of seven patients who all received FLUZONE SV 2009-2010 (lot number U3186AA): One patient experienced blurry vision, ringing in ears, and subsequently became pale and unresponsive; the six other patients all experienced localized injection site reactions. Initial report received on 08 September 2009 from a health care professional. An 18 year old female patient, with no medical history and no illness at the time of vaccination, received first intramuscular injection of FLUZONE SV 2009-2010 (lot number U3186AA) in the right arm on 04 September 2009 at 10:15. The patient had no concomitant medications and no adverse events following prior vaccination. Seven minutes after vaccination, at 10:22, the patient was standing at the check-out window and stated that she couldn't see, her vision blurry and her ears ringing. The patient was asked to sit down and she was given a lollipop since she hadn't eaten breakfast. The patient was talking, and while the physician was examining her, she became pale, unresponsive, her eyes closed, she slumped in her chair and stiffened. Then her eyes opened and her pupils were dilated. Suddenly, the patient became unresponsive again. She then returned to her baseline in less than 30 seconds in total. The patient's outcome was recovered. The same healthcare professional reported the seven events, which are captured in: 2009-03859, 2009-03804, 2009-03805, 2009-03806, 2009-03807, 2009-03808, and 2009-03809.
Pt was given an additional dose of Pfizer Bivalent vaccine. First was given on 10/06/2022 and another on 2/8/23. Pt made aware of this after it was discovered. She did not have any symptoms prior to leaving facility after waiting her 15 minutes.
stored in freezer/It was not administered; This case was reported by a pharmacist via call center representative and described the occurrence of intercepted product storage error in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced intercepted product storage error. On an unknown date, the outcome of the intercepted product storage error was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported but was captured as an adult as per vaccine indication. The Shingrix vaccine was stored in the freezer by mistake but it was not administered to the patients, which led to intercepted product storage error. No lot number or expiration date provided and the reporter informed stability conditions. The reporter did not consent to follow-up.
It appears the injection was high and toward the back of my arm verses the center of my deltoid...symptoms started with a headache and feeling flushed....then awoke around 11:30pm with chills, fever 100.5, and horrible body aches..missed work the following day...took tylenol and NSAIDS and sleep all day Thursday...Friday, today doing better but still feeling feverish, and still taking Tylenol every 6 hours
Expired dose of Kinrix was administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date 07-MAY-2023) for prophylaxis.   On 11-MAY-2023, the patient received Kinrix. On 11-MAY-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired dose of Kinrix was administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 11-MAY-2023 The reporter stated that Kinrix was administered which was already expired on 7th May 2023, which led to expired vaccine used.  the vaccine administration facility is the same as primary reporter. The reporter did not consent to follow up via mail.
patients received Moderna Bivalent vaccine past it's beyond use date; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients received Moderna Bivalent vaccine past it's beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 044H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients received Moderna Bivalent vaccine past it's beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients received Moderna Bivalent vaccine past it's beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (patients received Moderna Bivalent vaccine past it's beyond use date).    No concomitant medication were reported. Nurse Manager was not aware of any other Adverse Reactions. No treatment information was provided by the reporter.  This case contains information for the 3rd out of 3 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-712104, US-MODERNATX, INC.-MOD-2023-712108 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-712104:(Document) Monovalent case US-MODERNATX, INC.-MOD-2023-712108:Patient 1
dizziness that comes and goes; Vaccination site discomfort; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Vaccination site discomfort) and DIZZINESS (dizziness that comes and goes) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE DISCOMFORT (Vaccination site discomfort). On 25-Mar-2021, the patient experienced DIZZINESS (dizziness that comes and goes). The patient was treated with DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (Vaccination site discomfort) and DIZZINESS (dizziness that comes and goes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter  Treatment information was not provided
administered menactra to a 12-year-old patient which is a dose too early with no reported adverse event; Initial information received on 12-Aug-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 12 years old male patient and it was reported that menactra (MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE) was administered to a 12-year-old patient which is a dose too early with no reported adverse event while receiving vaccine [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV VACCINE VLP RL1 4V (YEAST) (GARDASIL) for Immunisation; COVID-19 VACCINE (COVID-19 VACCINE) for Immunisation; and TETANUS VACCINE (TETANUS VACCINE) for Immunisation.  On 05-Aug-2022, the patient received a  dose of 0.5 ml of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (formulation, strength: unknown) lot U7483AA via intramuscular route in the right deltoid as immunization.  On 05-AUG-2022 the patient was administered menactra which is a dose too early with no reported adverse event (inappropriate schedule of product administration) same day following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event (administered menactra to a 12-year-old patient which is a dose too early with no reported adverse event).  At time of reporting, the outcome was Unknown for the event.    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Rash starting around his wrists then moving to his legs and stomach; Itching; This case was reported by a consumer via call center representative and described the occurrence of rash in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th October 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. In October 2020, less than a day after receiving Shingrix, the patient experienced rash and pruritus. On an unknown date, the outcome of the rash and pruritus were not recovered/not resolved.   The reporter considered the rash and pruritus to be related to Shingrix.  Additional details were as follows: The age at vaccination was not reported. Consumer reported that he received the firste dose of shingrix on 5th october,2020 and had events like break out in a rash started around his wrists then moved to his legs and stomach.  He reported itching as well which started at the same time. The symptoms still have not resolved. The reporter consented to follow up.
I experienced pain in my left shoulder after my J&J vaccine, have trouble any pushups. My pain is constant in my left arm above my head. The day I went to the doctor, a guy crashed into me and the pain I experienced was more. I can put my fingers into my shoulder region and it is very painful.  I saw a doctor 04-23-2021 ad he advised me if my symptoms persists I should come back for a re-evaluation. I can not put my left arm first, my left arm is unstable.  Before the J&J vaccine, I did not have this pain to my left shoulder.  I have also taken OTC Tylenol but it does not help with my pain.
Next day post vax, the pt awoke with nausea, chills, headache, low back pain, and fever. Medicated with Tylenol.
Raised area at the site of the injection (swollen) and itching. Started today, 1-14-21
This spontaneous case reported by a consumer, describes the occurrence of peripheral swelling (swollen left foot) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 044A214) for COVID-19 immunization. No medical history reported. On Mar 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 29, 2021, patient experienced peripheral swelling (swollen left foot). At the time of the report, peripheral swelling (swollen left foot) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided.
My arm is red below the shot site; warm below the shot site; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th March 2020, the patient received Shingrix. In March 2020, less than a week after receiving Shingrix, the patient experienced erythema of extremities and skin warm. On an unknown date, the outcome of the erythema of extremities and skin warm were unknown.   It was unknown if the reporter considered the erythema of extremities and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not reported. The age group was not reported but was selected as an adult as per vaccine indication. The patient received Shingrix and experienced arm red and warm below the shot site. It has been 6 days since shot.
17 y F vaccinated with J&J vaccine. Pt reported to check in to be 18 years of age and was given the Janssen Vaccine. Post vaccination it was subsequently found that the patient was 17 years of age. Pt monitored and did not have any adverse reactions during this period.
Both feet both legs and back side. Red dots all over then turned to large red blotches, it burning and both feet and legs ached. I was given Flu shot and PREVNAR 13 same time.
I recv'd Pfizer 4/28/21 @ 2pm in my right arm.  I signed up for 'V-Safe,' answered my questions for the 5-6days every afternoon, but on day 7 I had very odd symptoms.  Vaccine site began to hurt, is warm, swollen & itchy, but what hurts the most is my neck, and my Right Lymph node is painful, swollen & hard,  But I was no longer able to report.  I also have headaches related to the Right neck pain.
Patient felt headache, Body ache and tiredness. After one day she had Rash and red hard bump at inject site.
01/22/2022 Achy, harder to breath, used inhaler from the pneumonia and RSV exposure one month earlier from kids from day care. Patient thought she was having a relapse from prior medical issue. However, she works with homeless population and had an exposure to COVID was tested positive COVID 01/24/2022.
Pt claims that as soon as she left the pharmacy, she experienced severe pain all over her body that kept her up all night, as well as GI upset. Says pain has remained constant. She called the pharmacy the morning of 9/11/19 to report it. RPh instructed her to contact her PCA and to seek medical attention if her pain gets worse or doesn't resolve in the next day.
Information has been received from a consumer, regarding his 16 year old daughter with no pertinent medical history, who "about 4 months ago" was vaccinated with a dose of Gardasil (Lot # not provided). There was no concomitant medication. Subsequently, (time following vaccination not specified), the patient developed vaginal lesions that "looked like cigarette burns." At the time of this report, the patient had not recovered. The father added that his daughter had not continued with the Gardasil vaccine series. The patient sought unspecified medical attention. Additional information has been requested.
It started on the next day with the usual aches and tiredness. The next day I noticed that all my muscles were still tight especially in my hip and quads area. It continued to get worse to get worse to where I was not able to do my physical therapy or the walks. It truly hurt. It was a 6 or 7 on a scale of 1-10. I took heavy dose of ibuprofen, but the pain continued. Friday was the worse. I went to the doctor, and he told me to go back and start the physical therapy again and to gradually start walking. He also advised me to continue to take the ibuprofen for pain. My pain is about a 2 in my quads and I walked this morning for a short period, so the symptoms are not gone but are getting better.
Following administration of vaccines the child appeared to go limp and faint then straightened out and had clonic type movements, lasted several seconds did not seem confused on groggy when it stopped. Child upset and was crying. About 5-10 minutes following pt reported that arms & both legs hurt. Was wobbly, walking.
Two days after receiving influenza vaccine the child developed a rash around his mouth.  Mother reports that he also became nauseated and began vomiting. Reports that he also developed diarrhea at this time. Reports that she took him to his physician two days later and was diagnosed with egg allergy by "blood testing."  No medication was provided by physician or any further treatment. Family has now moved and may be reached at the above cell phone number.
mom reported red, blotchy rash (to ER personnel) on face & forehead & uncontrollable/inconsolable crying episode >3hr;
SOME SIDE EFFECTS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced some side effects. The action taken with covid-19 vaccine  was not applicable. The outcome of some side effects was not reported. This report was non-serious.
Shortness of breath, orthopnea,  dyspnea on exertion, lower extremity swelling.  Patient cannot lie down to sleep.  Symptoms worsening over 1 week.   O2 sats = 78 % on room air after ambulating.
Mother called to report fever of 102.7 degrees F with very tender & swollen arms & developed redness over entire body (TYLENOL; CLARITIN given) starting 3-4 hours after vaccines given. No breathing problems. Condition resolved after 24 hours.
Information has been received from a licensed practical nurse concerning an 18 year old female patient with red dye and penicillin allergy who on 17-MAR-2010 and 19-MAY-2010 was vaccinated with a first and second dose of GARDASIL (Lot # 662724/0313Y for both doses), 0.5 mL, IM. Concomitant therapy included LOESTRIN 24 FE. The nurse reported that on 20-MAY-2010 the patient had experienced swollen bottom lip, heel, hip, and wrist after receiving the second dose of GARDASIL. She had been taking BENADRYL. The patient called the office. At the time of this report, the patient was recovering. The licensed practical nurse considered "swollen bottom lip, heel, hip, and wrist" to be other important medical events. It was also stated that the patient had similar reaction when she was little with an unknown medication. Additional information has been requested.
Patient experienced a headache, dizziness and mild shortness of breath roughly 20-30 minutes after receiving the vaccine, the headache and shortness of breath dissipated after about 5-10 minutes of resting in a chair. The dizziness lasted roughly 10-15 minutes and went away with additional rest and some cold water.
Patient that received the vaccine is under 18 year old.. Patient is 17 years and 9 months old.   Patient did not have adverse event
I experienced Marked swelling from the left shoulder to below the elbow and about 85-90% circumferentially. The injection site was in my left upper arm. This lasted 4-5 days and I did visit my doctor's office as well as the pharmacy regarding the swelling. I used benadryl, ice, and extra strength tylenol for the discomfort. In December, I went to an orthopedic clinic regarding the residual pain and weakness in that arm. Further studies included x-rays, PT, MRI of shoulder due to loss of posterior muscle of the left shoulder, and referral to a Dr. of Physical Medicine & Rehabilitation. He requested another MRI of the neck, then specific PT orders.
Red, swollen area at injection site; Dizziness/Lightheadedness; Headache; Wheezing; Palpitations.
Seizure started about 3:30 pm day after vaccination didn't stop until EMS arrived and gave medication at about 3:50.  was air lift to hospital.   Only had 1 seizure.  took a long time to wake up and come back to baseline.  Had fever following but did not have more seizures.
12/23: Sore throat with ache 12/24: Runny nose 12/26: Productive cough
3/14/18 - Mom called to report swelling, pain and warmth on LA where received Flu and BEXSERO vaccine. Continued till 3/18 when mom reports area is much better. Mom concerned B/C pt. also extremely emotional for few days. Crying for no reason and mom read online this could be d/t BEXSERO vaccine. Sx have since resolved.
Swelling, redness left shoulder, pain with movement, occurred one day after, lasted 8 months.
Post vax, the pt developed fatigue. Treated in August 2000 for positive Lyme test with antibiotics.
Left arm continues to be sore and achy after 2 weeks of the 2nd vaccine.  Shoulder stiff and hurt when arm reaches forward or when bending forward.  Neck stiff and achy.  Left hand tingly and some numbness. Left arm week and left hand hurst when gripping.  Expected to have sore arm after 2nd even 3rd day .  4th day after2nd vaccine shoulder became sore and achy.  Arm continues to feel sore and even more difficult to move.  Never had issues with shoulder arm neck or fingers before.
Headache Fever - 105.2 Lightheaded/dizzy Rapid heartrate Short of breath All joints in the body extremely painful Rash and lump the size of the baseball at the injection site Small rash on neck and chest Symptoms lasted until Saturday 1/18/2020 noon except injection site reaction and rash on neck and chest
soreness s after first dose; This is a spontaneous report from a contactable consumer (patient, self-reported). A 75-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she received both doses of vaccine and had soreness s after first dose on an unspecified date. She preventatively took Advil before second dose because she heard that the second dose caused more side effects, therefore she wanted to be ahead of the side effects. The patient mentions that she later received notice from a friend that she was not supposed to do that. The patient would like to know if she has made the vaccine less effective o and she has not heard Dr. said anything against this. Outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
3 trips to ER from itching all over body.Tried Dupixent which didn't work now on Adbry